Risk misclassification can reshape the value case for risk-stratified breast screening. https://www.mattheneus.com/editorial/risk-stratified-breast-screening-misclassification-capacity-cost-effectiveness-2026-10-01 #HTA #HealthEconomics #EvidenceSynthesis

A €607 annual price threshold sharpens the value case for empagliflozin after myocardial infarction. https://www.mattheneus.com/editorial/pubmed-empagliflozin-post-mi-heart-failure-risk-price-threshold-2026-10-05 #HTA #HealthEconomics #Pharma

Germany’s Lynkuet assessment shows how comparative follow-up duration can determine added-benefit conclusions. https://www.mattheneus.com/editorial/g-ba-elinzanetant-breast-cancer-endocrine-vasomotor-oasis4-duration-gap-2026-10-01 #HTA #Pharma #HealthEconomics

Intelligent-knife evidence now needs to connect diagnostic accuracy with surgical and patient outcomes. https://www.mattheneus.com/editorial/pubmed-intelligent-knife-cancer-surgery-diagnostic-outcomes-evidence-gap-2026-10-06 #HTA #EvidenceSynthesis #HealthEconomics

New paper out in Medical Care: What are the effects of medicine specialty consults on outcomes among general medicine patients?

www.ovid.com/10.1097/MLR....

#HealthServicesResearch #HealthEconomics

Patient-relevant outcomes reach HTA decisions through four practical stages, from question framing to accountable use. https://www.mattheneus.com/editorial/ispor-patient-relevant-outcomes-four-stage-hta-framework-2026-10-06 #HTA #HealthEconomics #EvidenceSynthesis

Three reviews reveal a critical evidence gap in adult type 1 diabetes care in humanitarian settings. #HTA #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/pubmed-type1-diabetes-humanitarian-settings-evidence-gap-systematic-reviews-2026-10-06

Planning your trip to Santiago? Let us help you get inspired!

📖 Explore the Santiago brochure: www.healtheconomics.org/wp-content/u...

We can’t wait to welcome you to Santiago!

#IHEA #IHEA2027 #Santiago #Chile #HealthEconomics #ConferenceTravel #VisitChile

A 90-trial menopause review separates symptom effects from economic value. #HTA #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/acp-menopause-vasomotor-pharmacologic-treatment-systematic-review-value-2026-10-06

Gene therapy could dominate factor prophylaxis in Sweden's haemophilia B model. #HTA #HealthEconomics #Pharma https://www.mattheneus.com/editorial/pubmed-etranacogene-dezaparvovec-sweden-haemophilia-b-cost-effectiveness-2026-10-04

NEW Discounts for Students, Groups, Low/Middle Income Countries - Statistical Foundations of Data Science with R - Autumn School - UCL Centre for Applied Statistics Courses #healtheconomics

Five-year follow-up reshaped the French value assessment of ribociclib in early breast cancer. https://www.mattheneus.com/editorial/has-kisqali-ribociclib-early-breast-cancer-five-year-natalee-reassessment-2026-09-16 #HTA #Pharma #HealthEconomics

A three-year colorectal screening model projects $12.5 million in savings, showing how budget impact analysis can guide adoption. #HTA #HealthEconomics #Pharma https://www.mattheneus.com/editorial/pubmed-next-generation-multitarget-stool-dna-idn-budget-model-2026-10-01

[External] nep-hea 2026-10-05, twenty-one papers #healtheconomics

A 66-per-QALY result is compelling only when the model's internal consistency holds up. https://www.mattheneus.com/editorial/pregnancy-measles-screening-cost-effectiveness-model-consistency-2026-10-01 #HTA #HealthEconomics #RWE

HE/HTA/DCE/RWD/Survival Analysis 2027 Courses - HEHTA Uni. of Glasgow #healtheconomics

Open Guest Lecture by Nataliia Kovalenko
«Donor Coordination and International Aid in Health Reconstruction»

Wed 7 October, 12:00–13:00
Aud 4, Harald Schjelderups hus, (Forskningsv 3A)
Open to everyone with an interest in the Ukrainian health sector
#Ukraine #healtheconomics

PBAC recommends Palynziq for phenylketonuria after revised pricing, showing how financial arrangements can unlock access. https://www.mattheneus.com/editorial/pbac-palynziq-final-outcome-financial-arrangement-2026-07 #HTA #Pharma #HealthEconomics

A 13-trial review maps early analgesia options in acute pancreatitis, highlighting evidence to support treatment decisions. https://www.mattheneus.com/editorial/pubmed-acute-pancreatitis-early-analgesia-randomised-trials-2026-10-01 #HTA #EvidenceSynthesis #HealthEconomics

WINTER HESG 2027 – FINAL CALL FOR ABSTRACTS – CLOSES TODAY (05/10/26) AT 5PM #healtheconomics